Oncovir

Biotechnology company developing Hiltonol® immunotherapy for cancer and infectious diseases

placeWashington, DC, District Of Columbia, United States calendar_todayFounded 2004 groups5 employees language oncovir.com

Social engagement

Social engagement: 396 social following, 2 posts in the last 12 months — top quartile of its industry.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

17 Nov 2025
Recognition
Coming soon